[PHARMA] QoQ Cumulative Quarter Result on 30-Jun-2019 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Jun-2019 [#2]
Profit Trend
QoQ- 47.31%
YoY- 25.75%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 819,921 2,820,530 2,104,847 1,387,998 786,108 2,384,956 1,788,312 -40.51%
PBT 30,880 -191,865 46,609 42,724 30,243 70,220 58,280 -34.49%
Tax -8,465 42,418 -17,323 -13,814 -10,595 -26,990 -19,620 -42.87%
NP 22,415 -149,447 29,286 28,910 19,648 43,230 38,660 -30.44%
-
NP to SH 22,399 -149,219 29,379 28,898 19,617 42,468 38,031 -29.71%
-
Tax Rate 27.41% - 37.17% 32.33% 35.03% 38.44% 33.67% -
Total Cost 797,506 2,969,977 2,075,561 1,359,088 766,460 2,341,726 1,749,652 -40.74%
-
Net Worth 350,047 336,573 516,387 518,564 528,825 509,862 522,618 -23.42%
Dividend
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Div 15,673 22,177 22,168 22,149 15,630 41,621 36,401 -42.95%
Div Payout % 69.98% 0.00% 75.46% 76.65% 79.68% 98.01% 95.71% -
Equity
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Net Worth 350,047 336,573 516,387 518,564 528,825 509,862 522,618 -23.42%
NOSH 261,229 261,229 261,229 261,229 260,505 260,505 260,505 0.18%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 2.73% -5.30% 1.39% 2.08% 2.50% 1.81% 2.16% -
ROE 6.40% -44.33% 5.69% 5.57% 3.71% 8.33% 7.28% -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 313.87 1,081.04 807.07 532.65 301.76 916.82 687.79 -40.69%
EPS 8.57 -57.19 11.26 11.09 7.53 16.33 14.63 -29.96%
DPS 6.00 8.50 8.50 8.50 6.00 16.00 14.00 -43.12%
NAPS 1.34 1.29 1.98 1.99 2.03 1.96 2.01 -23.66%
Adjusted Per Share Value based on latest NOSH - 261,229
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 56.89 195.70 146.04 96.30 54.54 165.48 124.08 -40.51%
EPS 1.55 -10.35 2.04 2.01 1.36 2.95 2.64 -29.86%
DPS 1.09 1.54 1.54 1.54 1.08 2.89 2.53 -42.92%
NAPS 0.2429 0.2335 0.3583 0.3598 0.3669 0.3538 0.3626 -23.42%
Price Multiplier on Financial Quarter End Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 -
Price 1.26 2.06 2.44 2.84 2.27 2.78 2.89 -
P/RPS 0.40 0.19 0.30 0.53 0.75 0.30 0.42 -3.19%
P/EPS 14.69 -3.60 21.66 25.61 30.14 17.03 19.76 -17.92%
EY 6.81 -27.76 4.62 3.90 3.32 5.87 5.06 21.87%
DY 4.76 4.13 3.48 2.99 2.64 5.76 4.84 -1.10%
P/NAPS 0.94 1.60 1.23 1.43 1.12 1.42 1.44 -24.72%
Price Multiplier on Announcement Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 19/11/18 -
Price 1.88 2.04 2.21 2.66 2.36 2.76 3.09 -
P/RPS 0.60 0.19 0.27 0.50 0.78 0.30 0.45 21.12%
P/EPS 21.93 -3.57 19.62 23.99 31.34 16.91 21.13 2.50%
EY 4.56 -28.04 5.10 4.17 3.19 5.92 4.73 -2.40%
DY 3.19 4.17 3.85 3.20 2.54 5.80 4.53 -20.83%
P/NAPS 1.40 1.58 1.12 1.34 1.16 1.41 1.54 -6.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment